TyG Index Marker For Predicting Atherosclerosis In Symptomatic CAD Patients
- byDoctor News Daily Team
- 04 August, 2025
- 0 Comments
- 0 Mins

China: A recent study published in Cardiovascular Diabetology has shown the TyG index (triglyceride-glucose index) to be a useful marker for predicting carotid and coronary atherosclerosis in patients with symptomatic CAD, independent of hyperlipidemia and diabetes mellitus.
The researchers stated that the TyG index is of higher value for identifying both carotid and coronary atherosclerotic plaques than the fasting blood glucose (FBG) or triglyceride (TG) level alone.
Hyperlipidaemia and diabetes are both risk factors for coronary artery disease (CAD), and both are associated with a high triglyceride-glucose index. The TyG index is a marker of insulin resistance (IR) and its utility in detecting and predicting cardiovascular disease has been reported. However, few studies have shown it to be a helpful marker of atherosclerosis in patients with symptomatic CAD.
Xin Qi, Nankai University Affiliated Hospital, Tianjin, China, and colleagues aimed to demonstrate that the TyG index can serve as a valuable marker for predicting carotid and coronary atherosclerosis in CAD patients, irrespective of hyperlipidemia and diabetes.
1516 patients with symptomatic CAD were included who underwent both coronary artery angiography and carotid Doppler ultrasound in the Department of Cardiology at Tianjin Union Medical Center from 2016 to 2022. The Ln formula was used to determine the TyG index.
Patients were grouped and analyzed according to the absence or presence of hyperlipidemia and diabetes. Calculation and measurement were done of carotid intima-media thickness and the Gensini score. The patients were divided into four groups according to the TyG index quartile to investigate the relationship between the TyG index and carotid or coronary artery lesions in symptomatic CAD patients.
The study revealed the following findings:
· The TyG index showed a significant positive correlation with both coronary lesions and carotid plaques in symptomatic CAD patients.
· After adjusting for age, sex, BMI, smoking, hypertension, diabetes, and the use of antidiabetic and antilipemic agents, the risk of developing coronary lesions and carotid plaques increased across the baseline TyG index.
· The highest quartile (quartile 4) was associated with a greater incidence of coronary heart disease [OR = 2.55] and carotid atherosclerotic plaque [OR = 2.31] compared with the lowest quartile of the TyG index.
· When compared to the fasting blood glucose or triglyceride level, the TyG index had a greater area under the ROC curve for predicting coronary lesions and carotid plaques.
· The subgroup analysis demonstrated the TyG index to be an equally effective predictor of coronary and carotid artery disease, regardless of diabetes and hyperlipidemia.
"There was a positive relation between the TyG index and atherosclerosis regardless of conventional influencing factors," the researchers wrote.
According to the study results, the TyG index could serve as a good marker for coronary and carotid lesion prediction in symptomatic CAD patients, regardless of hyperlipidemia and diabetes.
"There is a need for more large-scale prospective investigations to clarify the mechanisms underlying this association," the team concluded.
Reference:
Li, J., Dong, Z., Wu, H. et al. The triglyceride-glucose index is associated with atherosclerosis in patients with symptomatic coronary artery disease, regardless of diabetes mellitus and hyperlipidaemia. Cardiovasc Diabetol 22, 224 (2023). https://doi.org/10.1186/s12933-023-01919-z
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Chennai: Fortis Healthcare Opens 250-Bedded 2nd Mu...
- 06 July, 2025
New Lab-On-A-Chip, Cheaper, Faster, On The Spot Di...
- 06 July, 2025
Steroids And Plasma Exchange Do Not Alter Prognosi...
- 14 February, 2020
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!